L arge arteries are comprised of vascular smooth muscle cells (SMCs) embedded within a complex, cell-derived extracellular matrix. Collagen and elastic fibers, the major constituents of the vascular matrix, are secreted and assembled by SMCs and confer tensile and elastic properties. In the medial layer of elastic arteries, elastin forms concentric fenestrated lamellar layers that intercalate with alternating rings of SMCs to form functional lamellar units. 1 In the aorta, elastic fibers represent the largest component of the extracellular matrix, contributing up to 50% of aortic dry weight. 2 A series of elegant reports has demonstrated a critical role for elastin in the regulation of vascular morphogenesis in mice. Elastin (eln)-null mice die shortly after birth because of aortic obstruction by SMC proliferation. 3 Heterozygous mice (eln ϩ/Ϫ ) are viable but produce Ϸ50% less elastin mRNA and protein these animals are hypertensive, exhibit thinner elastic lamellae, more lamellar units, decreased aortic compliance, and mild cardiac hypertrophy compared with eln ϩ/ϩ mice. 4 Extensive experimental studies have revealed that elevated arterial pressure is an adaptation to maintain cardiac output and tissue perfusion in spite of vessel stiffness, 5 whereas the increase in lamellar unit number is an adaptation to normalize wall stress. 6 In this issue of Circulation Research, Hirano et al report the phenotypic rescue of elastin-deficient mice by generation of a humanized elastin mouse. 7 Using a bacterial artificial chromosome encoding the entire human elastin gene (hBAC), they engineered mice to express functional human elastin (ELN) under the control of its native promoter. Several transgenic founder lines demonstrated at least 1 functional ELN insert and were capable of producing human elastin mRNA. Spatial and temporal expression of the human ELN transgene was similar to endogenous mouse elastin. Moreover, the hBAC mRNA product was appropriately spliced, and the protein was correctly secreted, assembled, and incorporated into mouse elastic fibers.
At first glance, it may seem surprising that human elastin can substitute for mouse elastin, considering the differences in exon splicing and the lower than average amino acid conservation between species. In retrospect, however, Hirano et al might have expected the 2 proteins to be interchangeable, because it is primarily the structure of the elastin protein that is important for function. The alternating hydrophobic and crosslinking domains of elastin are conserved throughout vertebrate evolution, 8 and it is this repetitive domain structure that promotes the self-assembly of elastin into fibrillar structures, 9 provides elastomeric properties, 10, 11 and stabilizes elastin to withstand repeated cycles of extension and recoil. 12 Transgenic expression of human elastin prevented lethality in the eln-null mouse, although the rescued animals expressed only 30% of normal elastin levels. In accordance with the lower elastin content, these animals exhibited a more severe cardiovascular phenotype than eln ϩ/Ϫ mice, evidenced by stiffer vessels, higher blood pressure, and greater cardiac hypertrophy. Introduction of the hBAC into the eln ϩ/Ϫ mice increased elastin content by 40%, and this resulted in a decrease in lamellar unit number and arterial pressure to levels measured in eln ϩ/ϩ mice, and partially restored vascular compliance. Taken together, these findings suggest a direct relationship between the amount of elastin produced (mouse and human combined) and the severity of the cardiovascular defect in mice. Thus, these mice might provide an elegant system for teasing apart the different thresholds for elastin expression which lead to specific abnormalities in elastic tissues. Indeed, these authors have also used this model to investigate elastin-dosing effects on lung development and susceptibility to smoke-induced emphysema. 13 In humans, ELN deficiency has been attributed to genetic diseases (reviewed by Milewicz et al 14 ) . However no relationship has been established between elastin protein levels and cardiovascular phenotype, although it likely exists based on the wide spectrum of cardiovascular disease severity in patients with elastin deficiencies. Some people hemizygous for ELN can survive into adulthood with little or no cardiovascular problems, whereas in others, the vascular system is severely compromised even before birth. 15 There are clearly other factors, most likely a combination of genetic and environmental, that influence the severity of elastin-related arteriopathy in humans. Population-specific differences in exon splicing and elastin deposition have recently been identified, 16 and 3 quantitative trait loci affecting elastin production have been mapped in rats. 17 Future research in humans and rodents will focus on identifying these important modifier genes, because they will be crucial to implementing successful genetic therapies.
Although certain physiological parameters were improved in the hBAC-null animals, other key functions of elastin were not examined in the current study. Studies of eln Ϫ/Ϫ mice have revealed that elastin is required to maintain SMC quiescence and circumferential orientation in vivo. 3 These studies are consistent with in vitro findings that insoluble elastin maintains SMC quiescence, whereas incompletely assembled or degraded elastin peptides promote cell proliferation. 18, 19 Although other matrix molecules, such as type I collagen, have been implicated in maintaining SMC quiescence, 20 the studies of elastin-deficient mice 3, 5, 7 suggest that in the immediate perinatal phase of development, elastin is the dominant factor. However, the functional consequence of altered SMC orientation remains unclear, as do the mechanisms by which elastin is able to direct SMC orientation and inhibit proliferation. Preliminary studies by Karnik et al 21 have begun to dissect these mechanisms, and it will be interesting to see how future studies define the processes involved.
Another benefit of the humanized mouse model is the potential to investigate aspects of ELN function and pathology that are not evident in the eln-null or eln ϩ/Ϫ mice. For example, supravalvular aortic stenosis (Online Mendelian Inheritance in Man no. 185500) is the most common cardiovascular manifestation of ELN haploinsufficiency in humans and frequently requires surgical correction 15 ; however, the eln ϩ/Ϫ mouse does not exhibit this phenotype. Hirano et al found that introduction of the hBAC to eln ϩ/Ϫ mice leads to thickening of the ascending aorta, which may prove to be better model to study SVAS. Moreover, using the humanized mouse, one can test the function of mutations in ELN that produce less severe phenotypes than haploinsufficiency, for example, mutations that affect elastin durability or susceptibility to proteolytic degradation.
In the current study, Hirano et al report copy numberindependent transgene expression coupled with very low expression levels, emphasizing the complexity of ELN regulation and suggesting that the mouse milieu is inadequate to recapitulate normal human gene expression. Whether mouse tissues lack specific transcription factors required to drive ELN expression or whether hBAC expression depends on distal regulatory sequences remains to elucidated. However, as future studies define the missing regulatory elements, humanized mice expressing clusters of relevant genes, rather than individual genes, are likely to be developed. Establishment of normal ELN expression levels in the mouse will provide the most valuable tool for studying ELN and give the greatest opportunity for the development of strategies to treat diseases involving elastin deficiency.
